search
Back to results

Health-eBrain Study (HeB)

Primary Purpose

Depression and Burden in Caregivers

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindoula
DANA
Sponsored by
AnthroTronix, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Depression and Burden in Caregivers focused on measuring Caregivers, Case Management, Alzheimer's Disease, Cognition, Caregiver Burden, Depression

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Females and males who regularly provide care for a person with Alzheimer's Disease
  • Between the ages of 45-75
  • Self-reported ability to speak and read English
  • Providing care for at least a year

Participants in the Intervention and Waitlist Control Arms must meet the following additional inclusion criteria:

  • Zarit Burden Inventory (ZBI) Score of 9+
  • Overall M3 score of 33+
  • M3 Depression score of 7+
  • Female Only
  • Minimum hours of caregiving a week must be equal to or greater than 20 hours

Exclusion Criteria:

  • Anyone with a known cognitive diagnosis
  • Anyone with color blindness
  • Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3
  • Failure to meet all inclusion criteria per arm

Sites / Locations

  • AnthroTronix Inc

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Intervention Arm

Waitlist Control Arm

Arm Description

Participants will receive the intervention, Mindoula plus DANA, which involves working with a case manager via an app for 12 weeks. The case manager will help the participant cope with the stresses of caregiving as well as remind them to use the DANA cognitive assessment app. This arm will also take the study's psychological surveys.

These participants will take psychological surveys and a usability questionnaire for the first 12 weeks of participation, then, for the 12 weeks following, take the psychological surveys along with DANA and a usability questionnaire.

Outcomes

Primary Outcome Measures

Change from baseline M3 Behavioral Scale score over 12 weeks

Secondary Outcome Measures

Change from baseline Zarit Burden Inventory score over 12 weeks
Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeks

Full Information

First Posted
August 3, 2016
Last Updated
June 29, 2018
Sponsor
AnthroTronix, Inc.
Collaborators
Bright Focus Foundation, Mindoula Health Inc., 21st Century Brain Trust, Geoffrey Beene Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT02903862
Brief Title
Health-eBrain Study
Acronym
HeB
Official Title
Caregivers Virtual Health eBrain Study II
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Could not meet enrollment requirement.
Study Start Date
July 2016 (Actual)
Primary Completion Date
July 2017 (Actual)
Study Completion Date
July 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AnthroTronix, Inc.
Collaborators
Bright Focus Foundation, Mindoula Health Inc., 21st Century Brain Trust, Geoffrey Beene Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purposes of this study are to (1) track dementia caregiver health indicators over 12 weeks, both with and without the Mindoula plus DANA intervention (case manager and mobile messaging and assessment applications) to determine if the intervention improves caregiver health and (2) obtain feedback from caregivers to inform on the design of future interventions.
Detailed Description
This study will track the mental status and cognition of caregivers with and without the Mindoula and DANA intervention and use subject feedback to aid in designing future interventions for caregivers. This is a remotely administered, virtual study targeting dementia caregivers who are mild to moderately depressed. Screening calls for online administration of four surveys to determine inclusion in the study arms. These surveys will be taken on the Health-eBrain website, both at baseline/screening and throughout participation. All other participation will be completed on the participant's mobile phone, and all psychological and cognitive tests will be self-administered. This study has a between-group design. Participants will be screened for eligibility and then randomized into each arm. The intervention arm will receive the Mindoula plus DANA intervention. The wait list control arm will take the psychological surveys at regular intervals then, after 12 weeks, be enrolled in the DANA-only observation group. The DANA-only group will take DANA and a usability questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression and Burden in Caregivers
Keywords
Caregivers, Case Management, Alzheimer's Disease, Cognition, Caregiver Burden, Depression

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
Participants will receive the intervention, Mindoula plus DANA, which involves working with a case manager via an app for 12 weeks. The case manager will help the participant cope with the stresses of caregiving as well as remind them to use the DANA cognitive assessment app. This arm will also take the study's psychological surveys.
Arm Title
Waitlist Control Arm
Arm Type
Other
Arm Description
These participants will take psychological surveys and a usability questionnaire for the first 12 weeks of participation, then, for the 12 weeks following, take the psychological surveys along with DANA and a usability questionnaire.
Intervention Type
Behavioral
Intervention Name(s)
Mindoula
Intervention Description
The Mindoula intervention is a combination of case management and a messenger application. Case managers monitor how the participant is doing and any needs and provide 24/7 support & assistance, including care coordination, treatment adherence, and matching the participant with providers and community resources. Each participant will be given an intake questionnaire to establish goals and behavioral health history. Participants will use the app and work with the case manager for 12 weeks.
Intervention Type
Device
Intervention Name(s)
DANA
Intervention Description
DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency. DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory. Intervention participants will take DANA weekly. The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.
Primary Outcome Measure Information:
Title
Change from baseline M3 Behavioral Scale score over 12 weeks
Time Frame
At baseline, and 4, 8, and 12 weeks.
Secondary Outcome Measure Information:
Title
Change from baseline Zarit Burden Inventory score over 12 weeks
Time Frame
At baseline, and 4, 8, and 12 weeks.
Title
Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeks
Time Frame
At baseline, and 4, 8, and 12 weeks.
Other Pre-specified Outcome Measures:
Title
Usability Questionnaire
Description
Survey on using DANA that will help the researchers better understand the development of technologies for this population
Time Frame
At baseline, and 4, 8, and 12 weeks.
Title
Paired Associates Learning
Description
The PAL assesses visual memory and new learning.
Time Frame
At baseline and 12 weeks
Title
PERMA Profiler
Description
This survey assesses five core element of psychological well-being and happiness - Positive emotions, Engagement, Relationships, Meaning, and Accomplishments - as well as subjective wellbeing and sense of loneliness.
Time Frame
At baseline and 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Females and males who regularly provide care for a person with Alzheimer's Disease Between the ages of 45-75 Self-reported ability to speak and read English Providing care for at least a year Participants in the Intervention and Waitlist Control Arms must meet the following additional inclusion criteria: Zarit Burden Inventory (ZBI) Score of 9+ Overall M3 score of 33+ M3 Depression score of 7+ Female Only Minimum hours of caregiving a week must be equal to or greater than 20 hours Exclusion Criteria: Anyone with a known cognitive diagnosis Anyone with color blindness Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3 Failure to meet all inclusion criteria per arm
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Corinna E Lathan, Ph.D
Organizational Affiliation
AnthroTronix, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
AnthroTronix Inc
City
Silver Spring
State/Province
Maryland
ZIP/Postal Code
20910
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
27099613
Citation
Lathan C, Wallace AS, Shewbridge R, Ng N, Morrison G, Resnick HE. Cognitive Health Assessment and Establishment of a Virtual Cohort of Dementia Caregivers. Dement Geriatr Cogn Dis Extra. 2016 Mar 22;6(1):98-107. doi: 10.1159/000444390. eCollection 2016 Jan-Apr.
Results Reference
background
Links:
URL
http://www.health-ebrainstudy.org
Description
Website where study is being conducted. Participants register and take their psychological surveys here.

Learn more about this trial

Health-eBrain Study

We'll reach out to this number within 24 hrs